Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABCL
DFTX
Add up to 3 more stocks
ABCL
AbCellera Biologics Inc.
-3.08%
$13.36-0.42Delayed quote: Oct 6, 2026, 11:10 AM EDT
Market Cap
$4.08B
52W Range
$2.75 - $15.02
DFTX
Definium Therapeutics, Inc.
-2.50%
$35.32-0.91Delayed quote: Oct 6, 2026, 11:10 AM EDT
Market Cap
$4.69B
52W Range
$12.88 - $49.20
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.55 | 5.10 |
| P/S Ratio | 61.63 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 61.6% | 0.0% |
| Operating Margin | -289.0% | 0.0% |
| Net Margin | -248.8% | 0.0% |
| ROE | -18.4% | -38.5% |
| ROA | -12.6% | -31.8% |
| ROIC | -17.9% | -23.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.77 | 6.95 |
| Quick Ratio | 12.63 | 6.95 |
| Debt/Equity | 0.15 | 0.04 |
| Interest Coverage | N/A | -30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.